Makhova Anna
- Adults and children
In 2011 graduated from the Tula State Medical University with a degree in General Medicine. In 2013 completed residency at the Chair of Oncology of the Moscow State Medical University named after I.M. Sechenov, specialty "Oncology".
2015 – 2018 - co-researcher in the framework of the international clinical study Monarch3 (devoted to the therapy of metastatic breast cancer);
2015 – participant of the Moscow Oncology School on the diagnostics and treatment of neuroendocrine tumors;
2015 – participant of the I International Scientific and Practical Forum "Modern Trends in the Treatment of Metastatic Prostate Cancer", Kazan;
2015 - member of the Moscow Oncology School on Oncourology, Moscow, Russia;
2015 – participant of the international conference in the framework of Monarch3 clinical trial, devoted to the treatment of metastatic breast cancer, Brussels, Belgium;
2016 – participant of the international conference "Progressing Individualized Treatment Strategies of Melanoma" Amsterdam, Netherlands;
2016 - training and presentation of a case report in the framework of Eurasia Masterclass in Clinical Oncology, European School of Oncology, Moscow, Russia;
2017 - training at the Eurasia Course on Gastrointestinal Malignancies, European School of Oncology, Moscow, Russia;
2018 - attended lecture course at the 9th Regional Oncology Forum, Krakow, Poland;
2020 - clinical internship at the breast cancer drug therapy department at MD Anderson Cancer Center, Madrid, Spain.
Experience
Specialization: melanoma, breast cancer, prostate cancer, malignant brain tumors, head and neck tumors, colon cancer, pancreatic cancer, ovarian cancer, cervical cancer, uterine cancer, lung cancer, stomach cancer, kidney cancer, bladder cancer.
Determination of diagnostic tactics and selection of optimal diagnostic methods for patients with suspected oncological process and with an established diagnosis;
Molecular genetic studies and bioprofiling of tumors;
Treatment of oncological diseases (chemo- and targeted therapy, immunotherapy).
She is a regular participant of oncology conferences.
Махова Анна
